Headlines FDA Approves Tear Production Device “It produces tears within seconds after gently touching it to the outside of the nose and pressing the ‘on’ button.” Published 5 months ago on June 8, 2020 By INVISION Staff Share Tweet ISSAQUAH, WA — Olympic Ophthalmics announced that the U.S. Food and Drug Administration has approved its prescription neurostimulation technology to temporarily increase acute tear production in adults. The technology, called iTEAR100, is an external neurostimulator approved to increase acute tear production. Sponsored Webinars Introducing Varilux® Comfort Max Lenses Webinars See Our Full Schedule of COVID-19 Webinars Webinars INVISION & Cleinman Present: The Re-Opening — Down & Dirty [Webinar Replay] The neurostimulator is a standalone, pocket-size device requiring only a 30-second or less application to the skin of the external nasal region. It was approved via a “de novo” request to the FDA. “Its application stimulates the trigeminal nerve, which results in activation of the parasympathetic nerve pathway that controls tear film homeostasis,” according to a press release from Olympic Ophthalmics. The neurostimulator was stated to be well tolerated and effective at temporarily increasing acute tear production, the company stated. It will be supplied through eye care provider channels for adults who would benefit from increased production of tears. The most common adverse effects in clinical trials were headache and dizziness in 2 percent to 3 percent of subjects. Advertisement “Olympic Ophthalmics is a team of entrepreneurs, clinicians, and investors with deep expertise in ophthalmology, neuromodulation, and medical devices, brought together to develop devices to lower treatment costs and provide high value therapies for ophthalmic diseases,” said Dr. Michael Gertner, founder and CEO. “FDA clearance is an exciting milestone for our team and more importantly, for patients. It is just the beginning of a new class of neuromodulation technologies in eye care.” The device “is easy and intuitive to use by patients,” said Dr. Cynthia Matossian, an investigator in the clinical studies and medical director at Matossian Eye Associates, an affiliate of Prism Vision Group. “It produces tears within seconds after gently touching it to the outside of the nose and pressing the ‘on’ button.” FDA reviewed results from two pivotal studies, one of which was a double-masked, randomized, sham-controlled multi-center study and the second, a multi-center six-month single-arm study in which subjects used the stimulator twice per day. Related Topics:Latest News Top click to Comment(Comment) Up Next Video: 11 ODs Share Their Stories of Being Black in America Don't Miss Video: Optometrist Describes the Moment 50 Looters Stormed Her Business INVISION Staff Since launching in 2014, INVISION has won 23 international journalism awards for its publication and website. Contact INVISION's editors at [email protected]. Advertisement SPONSORED VIDEO SPONSORED BY ESSILOR Introducing EssilorLuxottica 360 A new program powered by Essilor, Luxottica and EyeMed that is designed to help your practice improve traffic, visibility and patient experience while maximizing profitability. Learn More at 360.EssilorLuxottica.com You may like Being Civic-Minded Is Important, but So Is Not Alienating People National Leadership Team Development Series Continues Online Tonight Early Polling in INVISION’s Big Survey Puts One Presidential Nominee On Top By a Narrow Margin Promoted Headlines Introducing EssilorLuxottica 360 Essilor American Eyes 2020 — Safilo’s Celebration of U.S. Eye Care Professionals Continues Safilo Introducing C Life by Champion L'Amy Advertisement Latest Trending Videos John Marvin15 hours ago Being Civic-Minded Is Important, but So Is Not Alienating People Press Releases16 hours ago National Leadership Team Development Series Continues Online Tonight The Big survey2 days ago Early Polling in INVISION’s Big Survey Puts One Presidential Nominee On Top By a Narrow Margin Headlines2 days ago FDA Approves Kala’s Eysuvis for Dry Eye Press Releases2 days ago Inspecs and O’Neill Announce License Deal Photo Gallery3 weeks ago Washington Eye Doc Welcomes Autumn … and More Brain Squad Members in Their INVISION T-Shirts Headlines1 week ago Video: Car Crashes Into Optometry Office; 4 Taken to Hospital Photo Gallery1 week ago You Need to See These 28 Head-Turning Ways to Display Frames Headlines3 weeks ago Rocky Mountain University of Health Professions Plans Optometry College Best of the Best3 weeks ago No Qualified Opticians? No Problem. This Oregon Optical Owner Took Matters Into His Own Hands Headlines1 week ago Video: Car Crashes Into Optometry Office; 4 Taken to Hospital Sponsored Content2 months ago Introducing EssilorLuxottica 360 Sponsored Webinars2 months ago Introducing Varilux® Comfort Max Lenses Headlines2 months ago Video: Gandhi’s Eyeglasses Could Fetch $19K+ at Auction INVISION Podcast3 months ago Podcast: Talking with the Finest, Hippest of Them All About Why There are No Ball Point Pens in Her Shop Advertisement SubscribeBULLETINS Get the most important news and business ideas for eyecare professionals every weekday from INVISION. Advertisement Most Popular Headlines1 week ago Video: Car Crashes Into Optometry Office; 4 Taken to Hospital Photo Gallery1 week ago You Need to See These 28 Head-Turning Ways to Display Frames Press Releases1 week ago BVI Acquires Benz Research & Development The Big survey2 days ago Early Polling in INVISION’s Big Survey Puts One Presidential Nominee On Top By a Narrow Margin Press Releases16 hours ago National Leadership Team Development Series Continues Online Tonight Headlines4 days ago Co-Founder of National Optometric Association Dies at 93 Headlines2 days ago FDA Approves Kala’s Eysuvis for Dry Eye Cover Stories3 days ago Is Corporate Optometry the Future of Optometry?